|
Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients
RECRUITINGN/ASponsored by Karolinska Institutet
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2021-01-21
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04748237
Summary
The aim is to determine whether a diagnostic strategy including early coronary computed tomographic angiography in intermediate-risk patients presenting to the Emergency Department with chest pain reduces the composite endpoint of death, readmission because of myocardial infarction or unstable angina requiring revascularization.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Age≥18 years. 2. Within 24 hours from presenting to the ED with chest pain or other symptoms suggestive of coronary artery disease (CAD) 3. HEART-score \>3 (according to http://www.heartscore.nl/) 4. Written informed consent obtained Exclusion Criteria: 1. Any condition that may influence the patient's ability to comply with study protocol. 2. Acute MI 3. Known obstructive CAD (\>50%) or previous PCI or CABG. 4. Clear alternative diagnosis 5. Estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73m2 6. Major allergy to iodinated contrast media 7. Circumstances making high quality images unlikely. 8. Not a Swedish resident with a personal ID-number. 9. Pregnancy or breast feeding 10. Further investigation for CAD not indicated, due to limited life expectancy, quality of life or functional status 11. Previous inclusion in the trial
Conditions4
Acute Coronary SyndromeChest PainCoronary Artery DiseaseHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2021-01-21
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04748237